Ocular surface discomfort can be problematic after cataract surgery. Italian researchers tested the use of cyclosporine A 0.1 ...

Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn.

The topical treatment had no significant effect on total or central corneal fluorescence staining score.

Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified.

If you continue to have this issue please contact [email protected]. Switching to cyclosporine ophthalmic emulsion 0.09% significantly improved signs of dry eye disease. Improvements ...

Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform ...

产品活性：Cyclosporin A (Cyclosporine A) 是一种免疫抑制剂，能与亲环素结合，抑制 protein phosphatase 2B (PP2B/calcineurin) 活性的IC50 值为 7 nM。Cyclosporin A 也抑制 CD11a/CD18 粘附分子。 生物活性：Cyclosporin A (Cyclosporine A) ...

Department of Chemistry, University of Tennessee, Knoxville, Tennessee 37996, United States ...

Fintel reports that on March 18, 2025, RBC Capital initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a Outperform ...

Harrow, Inc. stock dropped 50% post Q3 2024, but Q4 previews and FY 2025 projections signal growth potential. Click here to ...

Damage or injury to nerves causes a painful condition called neuropathy. This article reviews the safety and evidence behind ...